Nastech Pharmaceutical Company Inc.
Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 1st, 2008
"The workforce reduction of approximately 50 employees will enable us to drive our key clinical development and RNAi programs forward in a more efficient manner for the benefit of our shareholders," stated Steven C. Quay, M.D., Ph.D., Chairman and CEO of Nastech. "The savings by this action are estimated to be not less than $11 million during the 2008 fiscal year."
Keywords: , Nastech Pharmaceutical Company...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 6 Day Dental & Orthodontics
Mighty Molar Man(R) Accepts Plano Mayor Pat Evans's Proclamation in Honor of National Dental Health Month - Abnormal Psychology
Abnormal Psychology, 2nd Edition Available Now - AcademyHealth
Report Lists Key Policy Questions Facing State, National Health Reform - Acne Vulgaris
Recent Studies Suggest Popular 'Diet Pill' Relacore Reduces Acne Breakouts - Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriters - Acrongenomics, Inc.
Acrongenomics on Track to Acquire Molecular Vision - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
